Article
Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance.
Pharmacogenomics - 1 Dec 2007
Skarke Carsten, Schuss Patrick, Kirchhof Anja, Doehring Alexandra, Geisslinger Gerd, Lötsch Jörn
Abstract excerpt
INTRODUCTION: Genetic variants in the prostaglandin-endoperoxide synthase 2 (PTGS2) gene, which codes for COX-2, have been identified to modulate the response to COX-2-inhibiting drugs and to be possible risk factors for the incidence or prognosis of cardiovascular or neoplastic diseases, Alzheimer's disease, multiple sclerosis, asthma or osteoarthritis. Clinical evidence thus suggests a clinical importance of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
